ACAD RADIOL 润色咨询

ACADEMIC RADIOLOGY

出版年份:1994 年文章数:1871 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:9.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1242104, encodeId=332a12421040a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:影响医学与核医学<br>经验分享:投稿之前是在这里学习的经验,现在也来反馈一下。这个杂志相对radiology,UR, UJR,在国内没有那么热门,不过现在影响因子也有5+了,在影像学杂志里还是很不错的。这个杂志很迅速,从投稿到接受一共不到两个月。返修时一共有五个审稿人,30多条意见,当时看到还是很崩溃的,但好不容易有个修改的机会,就按照审稿人的意见仔细的逐条回复和修改,最后答复审稿人的word都有五千多单词了。虽然改起来很累,但也说明了杂志质量的可靠性。提交返修稿后没多就收到接受邮件了,当时还在上夜班呢。好像第一次返修的依然发给之前的审稿人,但不需要所有审稿人都回复,我是五个审稿人中的两个回复没有问题就直接接受了。 也祝大家好运,投稿是真的不易(ಥ_ಥ), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be922516094, createdName=白云飘, createdTime=Tue Aug 30 18:25:21 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向:影响医学与核医学<br>经验分享:杂志社处理的很快,给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914339, encodeId=b70e914339c8, content=请教大家一下我是外科医生,我以第一作者的身份和我同科的几个同事与2名影像科医生投稿这个期刊,会不会因为我不是影像科医生被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40bb5225064, createdName=1478ad39m10暂无昵称, createdTime=Thu Jan 07 11:30:27 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:别选OA,发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248620, encodeId=21781248620ee, content=偏重的研究方向:影响医学与核医学;神经影像<br>经验分享:想咨询一下,这个杂志有没有默认同意预印本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0755319539, createdName=雪山q, createdTime=Tue Sep 13 10:34:50 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206441, encodeId=19111206441ff, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:杂志效率极高,看似只有3分,影像学老牌杂志,质量过关,但这个杂志其实没那么容易,一般都有4个审稿人,并且都要求意见很正面,否则就是拒稿,给我找了4个审稿人,因为其中一个审稿人说创新性不足拒稿,其他3个意见也就微不足道了,哎,结果悲催了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Sun Mar 27 20:00:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202976, encodeId=942512029e6e1, content=我就想问下,在这里拒搞的小伙伴,最后去投啦什么杂志?给我点出路吧?孩子马上毕业啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Wed Mar 16 01:08:26 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591483, encodeId=61d759148308, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:4月14日投稿,5月3日被拒,虽然有些不开心,但仔细看看人家的意见,确实还是比较中肯的,主编是2014年度北美放射学主席,可能对论文的要求高一些,我也根据退稿意见修正了论文,希望再投能够接受吧,虽然没中,但推荐大家试试这个期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c35259444, createdName=147fbd98m69(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058395, encodeId=fa611058395e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:审稿速度很快,提交才半天编辑就拒稿了,可以选择open access或者订阅,open aeecss的话版面费大概3000多美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44382219872, createdName=在路上-YANG, createdTime=Thu Oct 07 15:13:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969056, encodeId=d39d969056f2, content=审稿速度:1.0<br>经验分享:编辑3天拒稿,很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef615429929, createdName=ms3000001390890539, createdTime=Fri May 28 00:06:42 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
    2022-08-30 白云飘

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:影响医学与核医学
    经验分享:投稿之前是在这里学习的经验,现在也来反馈一下。这个杂志相对radiology,UR, UJR,在国内没有那么热门,不过现在影响因子也有5+了,在影像学杂志里还是很不错的。这个杂志很迅速,从投稿到接受一共不到两个月。返修时一共有五个审稿人,30多条意见,当时看到还是很崩溃的,但好不容易有个修改的机会,就按照审稿人的意见仔细的逐条回复和修改,最后答复审稿人的word都有五千多单词了。虽然改起来很累,但也说明了杂志质量的可靠性。提交返修稿后没多就收到接受邮件了,当时还在上夜班呢。好像第一次返修的依然发给之前的审稿人,但不需要所有审稿人都回复,我是五个审稿人中的两个回复没有问题就直接接受了。 也祝大家好运,投稿是真的不易(ಥ_ಥ)

    6

    展开6条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1242104, encodeId=332a12421040a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:影响医学与核医学<br>经验分享:投稿之前是在这里学习的经验,现在也来反馈一下。这个杂志相对radiology,UR, UJR,在国内没有那么热门,不过现在影响因子也有5+了,在影像学杂志里还是很不错的。这个杂志很迅速,从投稿到接受一共不到两个月。返修时一共有五个审稿人,30多条意见,当时看到还是很崩溃的,但好不容易有个修改的机会,就按照审稿人的意见仔细的逐条回复和修改,最后答复审稿人的word都有五千多单词了。虽然改起来很累,但也说明了杂志质量的可靠性。提交返修稿后没多就收到接受邮件了,当时还在上夜班呢。好像第一次返修的依然发给之前的审稿人,但不需要所有审稿人都回复,我是五个审稿人中的两个回复没有问题就直接接受了。 也祝大家好运,投稿是真的不易(ಥ_ಥ), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be922516094, createdName=白云飘, createdTime=Tue Aug 30 18:25:21 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向:影响医学与核医学<br>经验分享:杂志社处理的很快,给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914339, encodeId=b70e914339c8, content=请教大家一下我是外科医生,我以第一作者的身份和我同科的几个同事与2名影像科医生投稿这个期刊,会不会因为我不是影像科医生被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40bb5225064, createdName=1478ad39m10暂无昵称, createdTime=Thu Jan 07 11:30:27 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:别选OA,发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248620, encodeId=21781248620ee, content=偏重的研究方向:影响医学与核医学;神经影像<br>经验分享:想咨询一下,这个杂志有没有默认同意预印本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0755319539, createdName=雪山q, createdTime=Tue Sep 13 10:34:50 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206441, encodeId=19111206441ff, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:杂志效率极高,看似只有3分,影像学老牌杂志,质量过关,但这个杂志其实没那么容易,一般都有4个审稿人,并且都要求意见很正面,否则就是拒稿,给我找了4个审稿人,因为其中一个审稿人说创新性不足拒稿,其他3个意见也就微不足道了,哎,结果悲催了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Sun Mar 27 20:00:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202976, encodeId=942512029e6e1, content=我就想问下,在这里拒搞的小伙伴,最后去投啦什么杂志?给我点出路吧?孩子马上毕业啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Wed Mar 16 01:08:26 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591483, encodeId=61d759148308, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:4月14日投稿,5月3日被拒,虽然有些不开心,但仔细看看人家的意见,确实还是比较中肯的,主编是2014年度北美放射学主席,可能对论文的要求高一些,我也根据退稿意见修正了论文,希望再投能够接受吧,虽然没中,但推荐大家试试这个期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c35259444, createdName=147fbd98m69(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058395, encodeId=fa611058395e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:审稿速度很快,提交才半天编辑就拒稿了,可以选择open access或者订阅,open aeecss的话版面费大概3000多美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44382219872, createdName=在路上-YANG, createdTime=Thu Oct 07 15:13:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969056, encodeId=d39d969056f2, content=审稿速度:1.0<br>经验分享:编辑3天拒稿,很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef615429929, createdName=ms3000001390890539, createdTime=Fri May 28 00:06:42 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
    2022-02-08 ms6000000933123975

    偏重的研究方向:影响医学与核医学
    经验分享:杂志社处理的很快,给我推荐了转投杂志😂

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1242104, encodeId=332a12421040a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:影响医学与核医学<br>经验分享:投稿之前是在这里学习的经验,现在也来反馈一下。这个杂志相对radiology,UR, UJR,在国内没有那么热门,不过现在影响因子也有5+了,在影像学杂志里还是很不错的。这个杂志很迅速,从投稿到接受一共不到两个月。返修时一共有五个审稿人,30多条意见,当时看到还是很崩溃的,但好不容易有个修改的机会,就按照审稿人的意见仔细的逐条回复和修改,最后答复审稿人的word都有五千多单词了。虽然改起来很累,但也说明了杂志质量的可靠性。提交返修稿后没多就收到接受邮件了,当时还在上夜班呢。好像第一次返修的依然发给之前的审稿人,但不需要所有审稿人都回复,我是五个审稿人中的两个回复没有问题就直接接受了。 也祝大家好运,投稿是真的不易(ಥ_ಥ), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be922516094, createdName=白云飘, createdTime=Tue Aug 30 18:25:21 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向:影响医学与核医学<br>经验分享:杂志社处理的很快,给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914339, encodeId=b70e914339c8, content=请教大家一下我是外科医生,我以第一作者的身份和我同科的几个同事与2名影像科医生投稿这个期刊,会不会因为我不是影像科医生被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40bb5225064, createdName=1478ad39m10暂无昵称, createdTime=Thu Jan 07 11:30:27 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:别选OA,发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248620, encodeId=21781248620ee, content=偏重的研究方向:影响医学与核医学;神经影像<br>经验分享:想咨询一下,这个杂志有没有默认同意预印本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0755319539, createdName=雪山q, createdTime=Tue Sep 13 10:34:50 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206441, encodeId=19111206441ff, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:杂志效率极高,看似只有3分,影像学老牌杂志,质量过关,但这个杂志其实没那么容易,一般都有4个审稿人,并且都要求意见很正面,否则就是拒稿,给我找了4个审稿人,因为其中一个审稿人说创新性不足拒稿,其他3个意见也就微不足道了,哎,结果悲催了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Sun Mar 27 20:00:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202976, encodeId=942512029e6e1, content=我就想问下,在这里拒搞的小伙伴,最后去投啦什么杂志?给我点出路吧?孩子马上毕业啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Wed Mar 16 01:08:26 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591483, encodeId=61d759148308, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:4月14日投稿,5月3日被拒,虽然有些不开心,但仔细看看人家的意见,确实还是比较中肯的,主编是2014年度北美放射学主席,可能对论文的要求高一些,我也根据退稿意见修正了论文,希望再投能够接受吧,虽然没中,但推荐大家试试这个期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c35259444, createdName=147fbd98m69(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058395, encodeId=fa611058395e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:审稿速度很快,提交才半天编辑就拒稿了,可以选择open access或者订阅,open aeecss的话版面费大概3000多美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44382219872, createdName=在路上-YANG, createdTime=Thu Oct 07 15:13:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969056, encodeId=d39d969056f2, content=审稿速度:1.0<br>经验分享:编辑3天拒稿,很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef615429929, createdName=ms3000001390890539, createdTime=Fri May 28 00:06:42 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
    2021-01-07 1478ad39m10暂无昵称

    请教大家一下我是外科医生,我以第一作者的身份和我同科的几个同事与2名影像科医生投稿这个期刊,会不会因为我不是影像科医生被拒?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1242104, encodeId=332a12421040a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:影响医学与核医学<br>经验分享:投稿之前是在这里学习的经验,现在也来反馈一下。这个杂志相对radiology,UR, UJR,在国内没有那么热门,不过现在影响因子也有5+了,在影像学杂志里还是很不错的。这个杂志很迅速,从投稿到接受一共不到两个月。返修时一共有五个审稿人,30多条意见,当时看到还是很崩溃的,但好不容易有个修改的机会,就按照审稿人的意见仔细的逐条回复和修改,最后答复审稿人的word都有五千多单词了。虽然改起来很累,但也说明了杂志质量的可靠性。提交返修稿后没多就收到接受邮件了,当时还在上夜班呢。好像第一次返修的依然发给之前的审稿人,但不需要所有审稿人都回复,我是五个审稿人中的两个回复没有问题就直接接受了。 也祝大家好运,投稿是真的不易(ಥ_ಥ), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be922516094, createdName=白云飘, createdTime=Tue Aug 30 18:25:21 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向:影响医学与核医学<br>经验分享:杂志社处理的很快,给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914339, encodeId=b70e914339c8, content=请教大家一下我是外科医生,我以第一作者的身份和我同科的几个同事与2名影像科医生投稿这个期刊,会不会因为我不是影像科医生被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40bb5225064, createdName=1478ad39m10暂无昵称, createdTime=Thu Jan 07 11:30:27 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:别选OA,发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248620, encodeId=21781248620ee, content=偏重的研究方向:影响医学与核医学;神经影像<br>经验分享:想咨询一下,这个杂志有没有默认同意预印本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0755319539, createdName=雪山q, createdTime=Tue Sep 13 10:34:50 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206441, encodeId=19111206441ff, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:杂志效率极高,看似只有3分,影像学老牌杂志,质量过关,但这个杂志其实没那么容易,一般都有4个审稿人,并且都要求意见很正面,否则就是拒稿,给我找了4个审稿人,因为其中一个审稿人说创新性不足拒稿,其他3个意见也就微不足道了,哎,结果悲催了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Sun Mar 27 20:00:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202976, encodeId=942512029e6e1, content=我就想问下,在这里拒搞的小伙伴,最后去投啦什么杂志?给我点出路吧?孩子马上毕业啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Wed Mar 16 01:08:26 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591483, encodeId=61d759148308, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:4月14日投稿,5月3日被拒,虽然有些不开心,但仔细看看人家的意见,确实还是比较中肯的,主编是2014年度北美放射学主席,可能对论文的要求高一些,我也根据退稿意见修正了论文,希望再投能够接受吧,虽然没中,但推荐大家试试这个期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c35259444, createdName=147fbd98m69(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058395, encodeId=fa611058395e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:审稿速度很快,提交才半天编辑就拒稿了,可以选择open access或者订阅,open aeecss的话版面费大概3000多美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44382219872, createdName=在路上-YANG, createdTime=Thu Oct 07 15:13:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969056, encodeId=d39d969056f2, content=审稿速度:1.0<br>经验分享:编辑3天拒稿,很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef615429929, createdName=ms3000001390890539, createdTime=Fri May 28 00:06:42 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
    2022-10-26 12114defm22(暂无昵称)

    审稿速度:2.0 | 投稿命中率:75.0
    经验分享:别选OA,发在了增刊上。

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1242104, encodeId=332a12421040a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:影响医学与核医学<br>经验分享:投稿之前是在这里学习的经验,现在也来反馈一下。这个杂志相对radiology,UR, UJR,在国内没有那么热门,不过现在影响因子也有5+了,在影像学杂志里还是很不错的。这个杂志很迅速,从投稿到接受一共不到两个月。返修时一共有五个审稿人,30多条意见,当时看到还是很崩溃的,但好不容易有个修改的机会,就按照审稿人的意见仔细的逐条回复和修改,最后答复审稿人的word都有五千多单词了。虽然改起来很累,但也说明了杂志质量的可靠性。提交返修稿后没多就收到接受邮件了,当时还在上夜班呢。好像第一次返修的依然发给之前的审稿人,但不需要所有审稿人都回复,我是五个审稿人中的两个回复没有问题就直接接受了。 也祝大家好运,投稿是真的不易(ಥ_ಥ), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be922516094, createdName=白云飘, createdTime=Tue Aug 30 18:25:21 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向:影响医学与核医学<br>经验分享:杂志社处理的很快,给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914339, encodeId=b70e914339c8, content=请教大家一下我是外科医生,我以第一作者的身份和我同科的几个同事与2名影像科医生投稿这个期刊,会不会因为我不是影像科医生被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40bb5225064, createdName=1478ad39m10暂无昵称, createdTime=Thu Jan 07 11:30:27 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:别选OA,发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248620, encodeId=21781248620ee, content=偏重的研究方向:影响医学与核医学;神经影像<br>经验分享:想咨询一下,这个杂志有没有默认同意预印本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0755319539, createdName=雪山q, createdTime=Tue Sep 13 10:34:50 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206441, encodeId=19111206441ff, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:杂志效率极高,看似只有3分,影像学老牌杂志,质量过关,但这个杂志其实没那么容易,一般都有4个审稿人,并且都要求意见很正面,否则就是拒稿,给我找了4个审稿人,因为其中一个审稿人说创新性不足拒稿,其他3个意见也就微不足道了,哎,结果悲催了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Sun Mar 27 20:00:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202976, encodeId=942512029e6e1, content=我就想问下,在这里拒搞的小伙伴,最后去投啦什么杂志?给我点出路吧?孩子马上毕业啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Wed Mar 16 01:08:26 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591483, encodeId=61d759148308, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:4月14日投稿,5月3日被拒,虽然有些不开心,但仔细看看人家的意见,确实还是比较中肯的,主编是2014年度北美放射学主席,可能对论文的要求高一些,我也根据退稿意见修正了论文,希望再投能够接受吧,虽然没中,但推荐大家试试这个期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c35259444, createdName=147fbd98m69(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058395, encodeId=fa611058395e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:审稿速度很快,提交才半天编辑就拒稿了,可以选择open access或者订阅,open aeecss的话版面费大概3000多美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44382219872, createdName=在路上-YANG, createdTime=Thu Oct 07 15:13:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969056, encodeId=d39d969056f2, content=审稿速度:1.0<br>经验分享:编辑3天拒稿,很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef615429929, createdName=ms3000001390890539, createdTime=Fri May 28 00:06:42 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
    2022-09-13 雪山q

    偏重的研究方向:影响医学与核医学;神经影像
    经验分享:想咨询一下,这个杂志有没有默认同意预印本

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1242104, encodeId=332a12421040a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:影响医学与核医学<br>经验分享:投稿之前是在这里学习的经验,现在也来反馈一下。这个杂志相对radiology,UR, UJR,在国内没有那么热门,不过现在影响因子也有5+了,在影像学杂志里还是很不错的。这个杂志很迅速,从投稿到接受一共不到两个月。返修时一共有五个审稿人,30多条意见,当时看到还是很崩溃的,但好不容易有个修改的机会,就按照审稿人的意见仔细的逐条回复和修改,最后答复审稿人的word都有五千多单词了。虽然改起来很累,但也说明了杂志质量的可靠性。提交返修稿后没多就收到接受邮件了,当时还在上夜班呢。好像第一次返修的依然发给之前的审稿人,但不需要所有审稿人都回复,我是五个审稿人中的两个回复没有问题就直接接受了。 也祝大家好运,投稿是真的不易(ಥ_ಥ), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be922516094, createdName=白云飘, createdTime=Tue Aug 30 18:25:21 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向:影响医学与核医学<br>经验分享:杂志社处理的很快,给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914339, encodeId=b70e914339c8, content=请教大家一下我是外科医生,我以第一作者的身份和我同科的几个同事与2名影像科医生投稿这个期刊,会不会因为我不是影像科医生被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40bb5225064, createdName=1478ad39m10暂无昵称, createdTime=Thu Jan 07 11:30:27 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:别选OA,发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248620, encodeId=21781248620ee, content=偏重的研究方向:影响医学与核医学;神经影像<br>经验分享:想咨询一下,这个杂志有没有默认同意预印本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0755319539, createdName=雪山q, createdTime=Tue Sep 13 10:34:50 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206441, encodeId=19111206441ff, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:杂志效率极高,看似只有3分,影像学老牌杂志,质量过关,但这个杂志其实没那么容易,一般都有4个审稿人,并且都要求意见很正面,否则就是拒稿,给我找了4个审稿人,因为其中一个审稿人说创新性不足拒稿,其他3个意见也就微不足道了,哎,结果悲催了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Sun Mar 27 20:00:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202976, encodeId=942512029e6e1, content=我就想问下,在这里拒搞的小伙伴,最后去投啦什么杂志?给我点出路吧?孩子马上毕业啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Wed Mar 16 01:08:26 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591483, encodeId=61d759148308, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:4月14日投稿,5月3日被拒,虽然有些不开心,但仔细看看人家的意见,确实还是比较中肯的,主编是2014年度北美放射学主席,可能对论文的要求高一些,我也根据退稿意见修正了论文,希望再投能够接受吧,虽然没中,但推荐大家试试这个期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c35259444, createdName=147fbd98m69(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058395, encodeId=fa611058395e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:审稿速度很快,提交才半天编辑就拒稿了,可以选择open access或者订阅,open aeecss的话版面费大概3000多美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44382219872, createdName=在路上-YANG, createdTime=Thu Oct 07 15:13:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969056, encodeId=d39d969056f2, content=审稿速度:1.0<br>经验分享:编辑3天拒稿,很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef615429929, createdName=ms3000001390890539, createdTime=Fri May 28 00:06:42 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
    2022-03-27 隐形的翅膀

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:杂志效率极高,看似只有3分,影像学老牌杂志,质量过关,但这个杂志其实没那么容易,一般都有4个审稿人,并且都要求意见很正面,否则就是拒稿,给我找了4个审稿人,因为其中一个审稿人说创新性不足拒稿,其他3个意见也就微不足道了,哎,结果悲催了

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1242104, encodeId=332a12421040a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:影响医学与核医学<br>经验分享:投稿之前是在这里学习的经验,现在也来反馈一下。这个杂志相对radiology,UR, UJR,在国内没有那么热门,不过现在影响因子也有5+了,在影像学杂志里还是很不错的。这个杂志很迅速,从投稿到接受一共不到两个月。返修时一共有五个审稿人,30多条意见,当时看到还是很崩溃的,但好不容易有个修改的机会,就按照审稿人的意见仔细的逐条回复和修改,最后答复审稿人的word都有五千多单词了。虽然改起来很累,但也说明了杂志质量的可靠性。提交返修稿后没多就收到接受邮件了,当时还在上夜班呢。好像第一次返修的依然发给之前的审稿人,但不需要所有审稿人都回复,我是五个审稿人中的两个回复没有问题就直接接受了。 也祝大家好运,投稿是真的不易(ಥ_ಥ), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be922516094, createdName=白云飘, createdTime=Tue Aug 30 18:25:21 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向:影响医学与核医学<br>经验分享:杂志社处理的很快,给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914339, encodeId=b70e914339c8, content=请教大家一下我是外科医生,我以第一作者的身份和我同科的几个同事与2名影像科医生投稿这个期刊,会不会因为我不是影像科医生被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40bb5225064, createdName=1478ad39m10暂无昵称, createdTime=Thu Jan 07 11:30:27 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:别选OA,发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248620, encodeId=21781248620ee, content=偏重的研究方向:影响医学与核医学;神经影像<br>经验分享:想咨询一下,这个杂志有没有默认同意预印本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0755319539, createdName=雪山q, createdTime=Tue Sep 13 10:34:50 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206441, encodeId=19111206441ff, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:杂志效率极高,看似只有3分,影像学老牌杂志,质量过关,但这个杂志其实没那么容易,一般都有4个审稿人,并且都要求意见很正面,否则就是拒稿,给我找了4个审稿人,因为其中一个审稿人说创新性不足拒稿,其他3个意见也就微不足道了,哎,结果悲催了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Sun Mar 27 20:00:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202976, encodeId=942512029e6e1, content=我就想问下,在这里拒搞的小伙伴,最后去投啦什么杂志?给我点出路吧?孩子马上毕业啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Wed Mar 16 01:08:26 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591483, encodeId=61d759148308, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:4月14日投稿,5月3日被拒,虽然有些不开心,但仔细看看人家的意见,确实还是比较中肯的,主编是2014年度北美放射学主席,可能对论文的要求高一些,我也根据退稿意见修正了论文,希望再投能够接受吧,虽然没中,但推荐大家试试这个期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c35259444, createdName=147fbd98m69(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058395, encodeId=fa611058395e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:审稿速度很快,提交才半天编辑就拒稿了,可以选择open access或者订阅,open aeecss的话版面费大概3000多美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44382219872, createdName=在路上-YANG, createdTime=Thu Oct 07 15:13:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969056, encodeId=d39d969056f2, content=审稿速度:1.0<br>经验分享:编辑3天拒稿,很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef615429929, createdName=ms3000001390890539, createdTime=Fri May 28 00:06:42 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
    2022-03-16 ms6000000933123975

    我就想问下,在这里拒搞的小伙伴,最后去投啦什么杂志?给我点出路吧?孩子马上毕业啦。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1242104, encodeId=332a12421040a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:影响医学与核医学<br>经验分享:投稿之前是在这里学习的经验,现在也来反馈一下。这个杂志相对radiology,UR, UJR,在国内没有那么热门,不过现在影响因子也有5+了,在影像学杂志里还是很不错的。这个杂志很迅速,从投稿到接受一共不到两个月。返修时一共有五个审稿人,30多条意见,当时看到还是很崩溃的,但好不容易有个修改的机会,就按照审稿人的意见仔细的逐条回复和修改,最后答复审稿人的word都有五千多单词了。虽然改起来很累,但也说明了杂志质量的可靠性。提交返修稿后没多就收到接受邮件了,当时还在上夜班呢。好像第一次返修的依然发给之前的审稿人,但不需要所有审稿人都回复,我是五个审稿人中的两个回复没有问题就直接接受了。 也祝大家好运,投稿是真的不易(ಥ_ಥ), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be922516094, createdName=白云飘, createdTime=Tue Aug 30 18:25:21 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向:影响医学与核医学<br>经验分享:杂志社处理的很快,给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914339, encodeId=b70e914339c8, content=请教大家一下我是外科医生,我以第一作者的身份和我同科的几个同事与2名影像科医生投稿这个期刊,会不会因为我不是影像科医生被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40bb5225064, createdName=1478ad39m10暂无昵称, createdTime=Thu Jan 07 11:30:27 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:别选OA,发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248620, encodeId=21781248620ee, content=偏重的研究方向:影响医学与核医学;神经影像<br>经验分享:想咨询一下,这个杂志有没有默认同意预印本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0755319539, createdName=雪山q, createdTime=Tue Sep 13 10:34:50 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206441, encodeId=19111206441ff, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:杂志效率极高,看似只有3分,影像学老牌杂志,质量过关,但这个杂志其实没那么容易,一般都有4个审稿人,并且都要求意见很正面,否则就是拒稿,给我找了4个审稿人,因为其中一个审稿人说创新性不足拒稿,其他3个意见也就微不足道了,哎,结果悲催了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Sun Mar 27 20:00:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202976, encodeId=942512029e6e1, content=我就想问下,在这里拒搞的小伙伴,最后去投啦什么杂志?给我点出路吧?孩子马上毕业啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Wed Mar 16 01:08:26 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591483, encodeId=61d759148308, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:4月14日投稿,5月3日被拒,虽然有些不开心,但仔细看看人家的意见,确实还是比较中肯的,主编是2014年度北美放射学主席,可能对论文的要求高一些,我也根据退稿意见修正了论文,希望再投能够接受吧,虽然没中,但推荐大家试试这个期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c35259444, createdName=147fbd98m69(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058395, encodeId=fa611058395e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:审稿速度很快,提交才半天编辑就拒稿了,可以选择open access或者订阅,open aeecss的话版面费大概3000多美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44382219872, createdName=在路上-YANG, createdTime=Thu Oct 07 15:13:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969056, encodeId=d39d969056f2, content=审稿速度:1.0<br>经验分享:编辑3天拒稿,很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef615429929, createdName=ms3000001390890539, createdTime=Fri May 28 00:06:42 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
    2020-05-21 147fbd98m69(暂无昵称)

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:4月14日投稿,5月3日被拒,虽然有些不开心,但仔细看看人家的意见,确实还是比较中肯的,主编是2014年度北美放射学主席,可能对论文的要求高一些,我也根据退稿意见修正了论文,希望再投能够接受吧,虽然没中,但推荐大家试试这个期刊!

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1242104, encodeId=332a12421040a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:影响医学与核医学<br>经验分享:投稿之前是在这里学习的经验,现在也来反馈一下。这个杂志相对radiology,UR, UJR,在国内没有那么热门,不过现在影响因子也有5+了,在影像学杂志里还是很不错的。这个杂志很迅速,从投稿到接受一共不到两个月。返修时一共有五个审稿人,30多条意见,当时看到还是很崩溃的,但好不容易有个修改的机会,就按照审稿人的意见仔细的逐条回复和修改,最后答复审稿人的word都有五千多单词了。虽然改起来很累,但也说明了杂志质量的可靠性。提交返修稿后没多就收到接受邮件了,当时还在上夜班呢。好像第一次返修的依然发给之前的审稿人,但不需要所有审稿人都回复,我是五个审稿人中的两个回复没有问题就直接接受了。 也祝大家好运,投稿是真的不易(ಥ_ಥ), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be922516094, createdName=白云飘, createdTime=Tue Aug 30 18:25:21 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向:影响医学与核医学<br>经验分享:杂志社处理的很快,给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914339, encodeId=b70e914339c8, content=请教大家一下我是外科医生,我以第一作者的身份和我同科的几个同事与2名影像科医生投稿这个期刊,会不会因为我不是影像科医生被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40bb5225064, createdName=1478ad39m10暂无昵称, createdTime=Thu Jan 07 11:30:27 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:别选OA,发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248620, encodeId=21781248620ee, content=偏重的研究方向:影响医学与核医学;神经影像<br>经验分享:想咨询一下,这个杂志有没有默认同意预印本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0755319539, createdName=雪山q, createdTime=Tue Sep 13 10:34:50 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206441, encodeId=19111206441ff, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:杂志效率极高,看似只有3分,影像学老牌杂志,质量过关,但这个杂志其实没那么容易,一般都有4个审稿人,并且都要求意见很正面,否则就是拒稿,给我找了4个审稿人,因为其中一个审稿人说创新性不足拒稿,其他3个意见也就微不足道了,哎,结果悲催了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Sun Mar 27 20:00:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202976, encodeId=942512029e6e1, content=我就想问下,在这里拒搞的小伙伴,最后去投啦什么杂志?给我点出路吧?孩子马上毕业啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Wed Mar 16 01:08:26 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591483, encodeId=61d759148308, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:4月14日投稿,5月3日被拒,虽然有些不开心,但仔细看看人家的意见,确实还是比较中肯的,主编是2014年度北美放射学主席,可能对论文的要求高一些,我也根据退稿意见修正了论文,希望再投能够接受吧,虽然没中,但推荐大家试试这个期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c35259444, createdName=147fbd98m69(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058395, encodeId=fa611058395e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:审稿速度很快,提交才半天编辑就拒稿了,可以选择open access或者订阅,open aeecss的话版面费大概3000多美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44382219872, createdName=在路上-YANG, createdTime=Thu Oct 07 15:13:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969056, encodeId=d39d969056f2, content=审稿速度:1.0<br>经验分享:编辑3天拒稿,很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef615429929, createdName=ms3000001390890539, createdTime=Fri May 28 00:06:42 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
    2021-10-07 在路上-YANG

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:审稿速度很快,提交才半天编辑就拒稿了,可以选择open access或者订阅,open aeecss的话版面费大概3000多美元。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1242104, encodeId=332a12421040a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:影响医学与核医学<br>经验分享:投稿之前是在这里学习的经验,现在也来反馈一下。这个杂志相对radiology,UR, UJR,在国内没有那么热门,不过现在影响因子也有5+了,在影像学杂志里还是很不错的。这个杂志很迅速,从投稿到接受一共不到两个月。返修时一共有五个审稿人,30多条意见,当时看到还是很崩溃的,但好不容易有个修改的机会,就按照审稿人的意见仔细的逐条回复和修改,最后答复审稿人的word都有五千多单词了。虽然改起来很累,但也说明了杂志质量的可靠性。提交返修稿后没多就收到接受邮件了,当时还在上夜班呢。好像第一次返修的依然发给之前的审稿人,但不需要所有审稿人都回复,我是五个审稿人中的两个回复没有问题就直接接受了。 也祝大家好运,投稿是真的不易(ಥ_ಥ), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be922516094, createdName=白云飘, createdTime=Tue Aug 30 18:25:21 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191250, encodeId=aa3f11912509a, content=偏重的研究方向:影响医学与核医学<br>经验分享:杂志社处理的很快,给我推荐了转投杂志😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Tue Feb 08 22:32:36 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914339, encodeId=b70e914339c8, content=请教大家一下我是外科医生,我以第一作者的身份和我同科的几个同事与2名影像科医生投稿这个期刊,会不会因为我不是影像科医生被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40bb5225064, createdName=1478ad39m10暂无昵称, createdTime=Thu Jan 07 11:30:27 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:别选OA,发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248620, encodeId=21781248620ee, content=偏重的研究方向:影响医学与核医学;神经影像<br>经验分享:想咨询一下,这个杂志有没有默认同意预印本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0755319539, createdName=雪山q, createdTime=Tue Sep 13 10:34:50 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206441, encodeId=19111206441ff, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:杂志效率极高,看似只有3分,影像学老牌杂志,质量过关,但这个杂志其实没那么容易,一般都有4个审稿人,并且都要求意见很正面,否则就是拒稿,给我找了4个审稿人,因为其中一个审稿人说创新性不足拒稿,其他3个意见也就微不足道了,哎,结果悲催了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Sun Mar 27 20:00:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202976, encodeId=942512029e6e1, content=我就想问下,在这里拒搞的小伙伴,最后去投啦什么杂志?给我点出路吧?孩子马上毕业啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Wed Mar 16 01:08:26 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591483, encodeId=61d759148308, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:4月14日投稿,5月3日被拒,虽然有些不开心,但仔细看看人家的意见,确实还是比较中肯的,主编是2014年度北美放射学主席,可能对论文的要求高一些,我也根据退稿意见修正了论文,希望再投能够接受吧,虽然没中,但推荐大家试试这个期刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c35259444, createdName=147fbd98m69(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058395, encodeId=fa611058395e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:审稿速度很快,提交才半天编辑就拒稿了,可以选择open access或者订阅,open aeecss的话版面费大概3000多美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44382219872, createdName=在路上-YANG, createdTime=Thu Oct 07 15:13:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969056, encodeId=d39d969056f2, content=审稿速度:1.0<br>经验分享:编辑3天拒稿,很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef615429929, createdName=ms3000001390890539, createdTime=Fri May 28 00:06:42 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
    2021-05-28 ms3000001390890539

    审稿速度:1.0
    经验分享:编辑3天拒稿,很快

    0

共90条页码: 2/9页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分